This is the authors' abstract. We don't add key points for this paper.
In a previous work, we consistently detected in normal human serum, natural antibodies directed against tubulin, actin, thyroglobulin, myoglobin, fetuin, albumin, and transferrin. These results prompted us to check the sera of patients carrying either a multiple myeloma or a Waldenstrom’s macroglobulinemia for the presence of monoclonal Ig (Mlg) having antibody activity against the same antigens. Among the 62 Mlg studied against the seven above-mentioned antigens, one (IgAκ) was shown to bind extensively to tubulin, and four (1lgGк, 1IgGλ, IgMк and 1lgAλ) bound mainly to actin, but a significant binding was also found to occur with tubulin and thyroglobulin. In all cases, findings were as follows: 1 ) The binding was mediated by light and heavy chain isotypes corresponding to those of the Mlg. 2) The antibody function was located in the Fab fragments prepared by pepsin digestion of these Mlg. 3) The antibody function was inhibited by the antigens. Mlg with anti-tubulin activity was exclusively inhibited by tubulin, whereas the four Mlg binding mainly to actin were predominantly inhibited by actin, but they were also strongly inhibited by tubulin and thyroglobulin. Similar results were obtained with either the serum or the F(ab’)2 fragments. 4) The Fab fragments were tested for their capacity to stain, by immunocytologic procedures, cultured human hepatic cells previously treated with vinblastine. In the case of the serum exhibiting anti-tubulin activity, only paracrystals of tubulin were stained, whereas for the four Mlg exhibiting anti-actin activity, simultaneous staining of actin filaments and tubulin paracrystals was observed. Three main conclusions emerge: 1) There is a high incidence of Mlg possessing antibody activity directed against the cytoskeleton proteins. 2) These Mlg seem to share antibody specificities with natural antibodies. 3) In the latter case, it can be postulated that, at least for some patients, the Mlg may constitute the expansion of a clone producing a natural antibody.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Dighiero et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: